12
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      “Cannon-Ball” skin metastases as the presenting manifestation of lung adenocarcinoma

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sir, A 60-year-old male farmer (with a history of smoking 16 “bidis” per day for 40 years) presented with a history of multiple progressively increasing painless swellings on his anterior abdominal wall for the past 3 months. He also reported constitutional symptoms (anorexia and weight loss of approximately 40%). He had developed a cough with occasional blood-tinged sputum in the last month before presentation. On examination, seven large cutaneous nodules [Figure 1] were observed over the anterior abdominal wall with the largest being 3.7 cm × 2.1 cm. These were plum colored, hard, nontender without any discharge and ulceration. Rest of the physical examination was unremarkable. Chest radiograph showed a mass in the right hilum [Figure 2a] and computed tomography of the chest revealed a mass measuring 4.3 cm × 3.7 cm in the right upper lobe with loss of fat planes with right main pulmonary artery along with right hilar (level 10R) lymph nodes and multiple cutaneous nodules [Figure 2b]. A flexible bronchoscopic examination showed mucosal infiltration in the right upper lobe bronchus with occlusion of apical and posterior segments. Fine needle aspiration cytology from cutaneous nodules [Supplementary Figure 1, available as online-only material at www.lungindia.com] and endobronchial biopsy [Supplementary Figure 2, available as online-only material at www.lungindia.com] were consistent with adenocarcinoma lung. Immunochemistry of above specimens showed tumor cells to be positive for pan-CK (AE1/AE3) and for CK7 [Supplementary Figure 3a, available as online-only material at www.lungindia.com] and negative for both CK20 [Supplementary Figure 3a, available as online-only material at www.lungindia.com] and p63 [Supplementary Figure 3a, available as online-only material at www.lungindia.com]. HIV serology was nonreactive. The endobronchial biopsy specimen was negative for EGFR gene mutations by real-time ARMS-PCR assay and for ALK gene rearrangements by D5F3 immunohistochemistry. A diagnosis of stage IV NSCLC (EGFR and ALK wild-type adenocarcinoma; T4N1M1b) was made, and the patient initiated on chemotherapy with pemetrexed and carboplatin. Supplementary Figure 1 Fine needle aspiration cytology from cutaneous nodules showing features consistent with adenocarcinoma lung Click here for additional data file. Supplementary Figure 2 Endobronchial biopsy confirmed the diagnosis of lung adenocarcinoma Click here for additional data file. Supplementary Figure 3 Immunochemistry of fine needle aspiration cytology and endobronchial biopsy showed tumor cells to be positive for pan-CK (AE1/AE3) and for CK7 (a) and negative for both CK20 (b) and p63 (c) Click here for additional data file. Figure 1 (a and b) Clinical photograph showing large cutaneous nodules observed over the anterior abdominal wall Figure 2 Chest radiograph showed a mass in right hilum (a) and computed tomography of the chest revealed a mass in the right upper lobe with loss of fat planes with right main pulmonary artery along with right hilar (level 10R) lymph nodes and multiple cutaneous nodules (b) Skin metastases occur in cancer patients with a frequency from <1% to 10% although these account for only around 2% of all skin tumors.[1] In general, the presence or development of cutaneous metastases is a poor prognostic sign with expected survival ranging from weeks to months. The relative frequencies of cutaneous metastasis depend on gender and thereafter the relative frequency of different types of primary cancers in each gender. Therefore for women with cutaneous metastases, the most common sites of primary malignancies are breast, ovary, lung, and colorectal while in men, these are lung, colorectal, esophagus, pancreas, and stomach.[1 2] Cutaneous metastasis is an uncommon presenting manifestation of lung cancer. Adenocarcinoma is the most common histological type of lung cancer and also the type most commonly associated with cutaneous metastasis. In the index case, the diagnosis of adenocarcinoma was confirmed from both the primary (lung) and metastatic site (skin). As mentioned earlier, demonstration of adenocarcinoma histology in skin nodules can represent metastases from a variety of solid tumors including lung, breast, stomach, colon, pancreas, thyroid, and prostate. As per current IASLC/ERS/ATS recommendations and the WHO classification of lung tumors, a combination of microscopic features and immunochemistry (positive adenocarcinoma marker [CK-7] and negative squamous cell carcinoma marker [p63]) was used for establishing the diagnosis of lung adenocarcinoma in the index patient.[3 4] The absence of activating EGFR gene mutations and of ALK gene rearrangements was not unexpected for this clinical profile (heavy smoking, male gender).[3] Treatment for metastatic lung adenocarcinoma without actionable mutations remains chemotherapy with pemetrexed being the preferred drug to be used in the platinum doublet.[5] Historically, “Cannon-Ball” involvement of the dermis by lobules of pericyte-rich capillaries has been reported in acquired tufted angioma.[6] We use the term “Cannon-Ball” to describe cutaneous metastases observed in the index case whose appearance to the naked eye was similar to that seen on chest radiograph in case of pulmonary metastasis from a variety of extrathoracic primary cancers.[7] Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Rates of cutaneous metastases from different internal malignancies: experience from a Taiwanese medical center.

          Previous reports regarding the rates at which various internal tumors metastasize to the skin have been limited and have only included the Caucasian population. Moreover, the mechanisms that predispose certain internal malignancies to metastasize to the skin have rarely been discussed in the scientific literature. We determined the frequencies with which various internal malignancies metastasize to the skin in patients from a Taiwanese medical center. We also evaluated whether expressions of chemokine receptors CCR10 and CXCR4 by tumor cells correlate with cutaneous metastatic ability. Clinical records from Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, during 20 years (1986-2006) were reviewed and cases of biopsy-proven primary internal malignancies and cutaneous metastases were identified. Immunohistochemical staining with antibodies to CCR10 and CXCR4 was performed on a selected number of internal malignancies with and without skin metastases. From 12,146 patients with internal malignancies, we found 124 cases (1.02%) with cutaneous metastases. The highest rates of skin metastases were found to occur from carcinoma of the breast, followed by the lung, oral mucosa, colon and rectum, stomach, and esophagus. However, the rate of cutaneous metastasis from breast cancer was much lower compared with previous studies involving Caucasians. In general, adenocarcinomas gave rise to cutaneous metastases at a higher frequency compared with other histologic subtypes. In addition, the expressions of CCR10 and CXCR4 by tumor cells did not correlate well with the presence or absence of skin metastases. This study is retrospective in nature. Different internal malignancies metastasize to the skin with different frequencies, and the rates at which different malignancies metastasize to cutaneous sites differ between the Taiwanese and Caucasian populations. The mechanisms responsible for the cutaneous metastatic ability of certain malignancies likely involve factors other than chemokine receptors CCR10 and CXCR4, because their expressions by tumor cells are neither necessary nor sufficient for the formation of skin metastases.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classification and their impact on overall survival

            Background: There is limited Indian data on epidermal growth factor receptor (EGFR) gene activating mutations (AMs) prevalence and their clinicopathologic associations. The current study aimed to assess the relationship between EGFR AM and histologic subtypes and their impact on overall survival (OS) in a North Indian cohort. Patients and Methods: Retrospective analysis of nonsmall cell lung cancer patients who underwent EGFR mutation testing (n = 186) over 3 years period (2012–2014). EGFR mutations were tested using polymerase chain reaction amplification and direct sequencing. Patients were classified as EGFR AM, EGFR wild type (WT) or EGFR unknown (UKN). Histologically adenocarcinomas (ADC) were further categorized as per the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society-2011 classification. Results: Overall EGFR AM prevalence was 16.6%. The ratio of exon 19 deletions to exon 21 L858R mutations was 3.17:1. Female sex (P = 0.002), never smoking status (P = 0.002), metastatic disease (P = 0.032), and nonsolid subtype of ADC (P = 0.001) were associated with EGFR AM on univariate logistic regression analysis (LRA). On multivariate LRA, solid ADC was negatively associated with EGFR AM. Median OS was higher in patients with EGFR AM (750 days) as compared to EGFR-WT (459 days) or EGFR-UKN (291 days) for the overall population and in patients with Stage IV disease (750 days vs. 278 days for EGFR-WT, P = 0.024). On univariate Cox proportional hazard (CPH) analysis, smoking, poor performance status (Eastern Cooperative Oncology Group ≥ 2), EGFR-UKN status, and solid ADC were associated with worse OS while female sex and lepidic ADC had better OS. On multivariate CPH analysis, lepidic ADC (hazard ratio [HR] =0.12) and EGFR-WT/EGFR-UKN (HR = 2.39 and HR = 3.30 respectively) were independently associated with OS in separate analyses. Conclusions: Histologic subtyping of ADC performed on small biopsies is independently associated with EGFR AM and with better OS. EGFR AM presence is a positive prognostic factor for OS.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.

              Pemetrexed is the preferred treatment of nonsquamous non-small cell lung cancer (ns-NSCLC). Folic acid supplementation (FAS) (350 to 1000 μg daily PO) is recommended to minimize hematological toxicity (HTox). Elevated total plasma homocysteine (tpHcy) predicts increased risk of HTox with pemetrexed in absence of FAS. The current study aimed to assess prevalence of elevated tpHcy levels at baseline and after pemetrexed treatment. Association of graded tpHcy levels/FAS with toxicity was also assessed.
                Bookmark

                Author and article information

                Journal
                Lung India
                Lung India
                LI
                Lung India : Official Organ of Indian Chest Society
                Medknow Publications & Media Pvt Ltd (India )
                0970-2113
                0974-598X
                Sep-Oct 2017
                : 34
                : 5
                : 480-481
                Affiliations
                [1] Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India E-mail: navneetchd@ 123456yahoo.com
                [1 ] Department of Cytology and Gynecological Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
                [2 ] Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
                [3 ] Department of Dermatology, Venereology and Leprosy, Postgraduate Institute of Medical Education and Research, Chandigarh, India
                Article
                LI-34-480
                10.4103/lungindia.lungindia_3_17
                5592766
                28869239
                24bd3bf5-e91d-4e38-954d-b756d8c75a8e
                Copyright: © 2017 Indian Chest Society

                This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

                History
                Categories
                Case Letters

                Respiratory medicine
                Respiratory medicine

                Comments

                Comment on this article